A Prospective Phase 2 Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular Measurable Residual Disease and Early Relapse in Acute Myeloid Leukemia
| Autor: | Ing S Tiong, Devendra Hiwase, Emad Uddin Abro, Ashish Bajel, Emma Palfreyman, Sun Loo, Shaun Fleming, Chun Yew Fong, Tse-Chieh Teh, Adam Ivey, Andrew H Wei |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Blood. 140:1453-1455 |
| ISSN: | 1528-0020 0006-4971 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|